01 Opening Remarks

在人工智能与Medical Images深度融合的今天,乳腺Ultrasound(Ultrasound)正经历着前所未有的技术变革。 With the rapid iterative evolution of cutting-edge technologies such as in-depth learning, basic models, multi-modular integration, diagnostic models of mammography are accelerating the transition from traditional "manual reading" to "AI-assisted decision-making"。 本文将从疾病负担、技术突破、data价值、Clinical应用等多个Dimension,深度剖析乳腺Ultrasound(Ultrasound)AI的发展现状与未来趋势。

作为中国领先的Medical AI Data科技Company,Changsha Langhui Information Technology Co., Ltd.深耕Ultrasound(Ultrasound)Domains多年,构建了国内Reg模最大、Annotation Quality最高的乳腺ImagingDataset之一。 This dataset not only provides a solid data foundation for AI model training, but also sets a data quality benchmark for the entire industry。 Combining the latest research progress and industry practice, this article presents readers with a panoramic view of the development of breast AI。

Key Highlights of This Article

  • Data Support: Insight based on Longway 40,000+ case breast ultrasound data, mega-mammography data
  • Technology Frontier: The most noteworthy technological breakthrough in the Ultrasoon AI field in 2025-2026
  • Clinical Value: AI technology's landing path and value expression in real clinical scenes
  • Trend Analysis:Forward-Looking Analysis of Industry Regulation, Technology Evolution and Industrialization

02 Disease Burden and Clinical Challenges

Chinese women have about 420,000 new cases of breast cancer.
Epidemiological Data
High breast ultrasound positive.
Diagnostic Pain Points
Insufficient Primary Care Capability
The Primary Care Diagnosis and Treatment Gap

2.1 Disease Burden:A Public Health Challenge That Cannot Be Ignored

Chinese women have about 420,000 new cases of breast cancer.,是女性恶性肿瘤首位。Behind these figures lie the health challenges faced by tens of millions of patients and their families。 The incidence of breast-related diseases continues to increase as population ageing accelerates, lifestyles change and environmental factors influence。 Of even greater concern are the early absence of specific symptoms of many breast diseases and the fact that patients tend to be in the middle and late stages of the disease at the time of their visit, resulting in a significant reduction in the effectiveness of treatment and in the prognosis.。

以乳腺Ultrasoundas the core的Imaging学检查,是乳腺疾病诊断和治疗决策的基石。 然而,High breast ultrasound positive.——这一data深刻反映了当前乳腺Ultrasound(Ultrasound)诊断面临的核心挑战。 A considerable proportion of patients fail to receive an accurate diagnosis within the optimal treatment window, which not only delays treatment but also increases the medical burden and the suffering of patients。 How to improve the early diagnosis rate and accuracy of breast diseases is an important challenge currently facing clinical medicine。

2.2 Three Major Pain Points in Clinical Diagnosis

①

Low Diagnostic Efficiency

Ultrasund image analysis requires a great deal of time for doctors to observe and measure carefully. In a reality of stress on medical resources, radiologists continue to increase their workload, with longer reporting cycles, and affect patients’ timely treatment.

②

Insufficient Diagnostic Consistency

The Ultrasoon diagnosis is highly dependent on the professional experience and subjective judgement of doctors, and there are significant differences in the level of diagnosis between different levels of hospitals and senior doctors, leading to poor consistency in diagnosis and increased risk of error and omission.

③

Difficulties in Quantitative Assessment

Traditional manual diagnosis is dominated by qualitative description and lacks precise quantitative assessment capability。Yet the early identification of disease, assessment of treatment response and prognostic judgment often require precise quantitative analysis of lesions — precisely the weak point of manual diagnosis。

2.3 The Capability Gap in Primary Care

Insufficient Primary Care Capability。This data reveals a serious reality: the high-quality Ultrasoon diagnostic resources are concentrated in the big city's Triple Hospital. Primary-care medical institutions have obvious shortcomings in equipment, talent reserves and diagnostic capability。For the vast number of primary-care patients, obtaining high-quality breast imaging diagnostic services is not easy。

This uneven distribution of health-care resources not only exacerbates the social problem of "difficult and expensive" but also limits the spread of early detection of breast diseases.。 How to use artificial intelligence technology to break down geographical barriers and bring high-quality ultrasound diagnostic capability down to the primary care level, is one of the core issues that Changsha Langhui Information Technology Co., Ltd. has long focused on and is committed to solving。

"The ultimate goal of medical AI is not to replace doctors, but to ensure that every patient, wherever they are, can access homogenized, high-quality diagnostic services。 This is the mission that Langhui Technology has always upheld。"

—— Chief Scientist, Langhui Medical AI Research Institute

03 Limitations of Traditional Diagnosis and the AI Breakthrough

3.1 Four Major Limitations of Traditional Manual Diagnosis

Although ultrasound technology has made great strides over the past few decades, the traditional manual image reading model is facing more and more challenges。 From image acquisition and analytical interpretation to report generation, every stage has bottlenecks that are difficult to break through。

Strong subjectivity, poor consistency

Image diagnosis is essentially a subjective judgement of a doctor based on professional knowledge and clinical experience. Depending on personal experience, knowledge structure, working state, and even environmental factors, there may be significant differences in the diagnosis of the same case by different doctors.

Efficiency bottleneck, difficult to scale

An experienced video doctor can complete up to a dozen ultrasound diagnostics every day. In the face of growing demand for examinations, doctors’ workloads continue to increase and waiting times for reports continue to increase.

Information omission, limited insight

The human eye has limited capacity to capture and analyze image information, and subtle, occult lesion features in particular are prone to missed diagnosis。In addition, the human eye can hardly extract deep, invisible imaging features from massive volumes of image data, yet these features often carry important diagnostic and prognostic information。

Insufficient quantification, mostly subjective descriptions

Traditional imaging reports are dominated by qualitative description and lack precise quantitative assessment。For example, the size, shape and texture features of a lesion can often only be described with vague terms such as "enlarged", "reduced" or "heterogeneous"。This qualitative assessment approach cannot meet the needs of the precision medicine era for accurate quantification and dynamic monitoring of disease。

3.2 Core advantages of AI technology

以深度学习为代表的人工智能技术,正在从根本上改变乳腺Ultrasound(Ultrasound)的诊断范式。 AI has the following irreplaceable advantages over traditional artificial diagnosis:

Relative dimensions
Traditional Manual Diagnosis
AI-Assisted Diagnosis
Diagnostic Efficiency
15-30 minutes per case
10-30 seconds per case, an improvement of 50-100 times
Diagnostic Consistency
Kappa 0.5-0.7
Kappa 0.85-0.95
Quantitative Analysis
Mainly Subjective Description
Fully Automated Precise Quantification
Business Hours
Constrained by Manpower
Uninterrupted 7×24 operation
Homogenization Capability
Huge Regional Disparities
Standardized output, homogenized diagnosis

3.3 Triple value of AI breakdown

人工智能技术在乳腺Ultrasound(Ultrasound)Domains的应用,不仅仅是效率的提升,更是诊断模式的根本变革。 Its core values are reflected at three levels:

Improved Diagnostic Quality

AI can detect micropathic changes that are easily missed in human eyes and improve early detection rates; at the same time, it provides more accurate diagnostic information through quantitative analysis and supports doctors in making more accurate clinical decisions.

A Revolution in Diagnostic Efficiency

AI has liberated doctors from heavy and repetitive work, significantly reduced reporting times, improved overall efficiency of the unit and allowed doctors more time to focus on difficult cases and clinical decision-making.

Healthcare Homogenization

Through AI technology, the primary health care facilities are empowered to provide quality video diagnostics across geographical limits, to achieve parity in the quality of diagnostics between different levels of hospitals and to assist in the level-segregation of diagnostics.

"AI is not the opponent of doctors, but their assistant。A good AI system should be like a tireless, highly experienced 'super assistant', helping doctors see more accurately, faster and more comprehensively。"

—— Chief Medical Officer, Changsha Langhui Information Technology Co., Ltd.

04 2025-2026 Frontier Technology Breakthroughs

The period from 2025 to 2026 is a critical phase of accelerated iteration in ultrasound AI technology。Foundation models, self-supervised learning, Multimodal Fusion(Multimodal Fusion)等Frontier技术的快速发展,正在将乳腺ImagingAI推向一个全新的高度。 The following are the five technology breakthrough directions most worthy of attention in this field。

4.1 Base model: from "special AI" to "general AI" Viet.

长期以来,乳腺Ultrasound(Ultrasound)AIModels大多是针对单一Tasks进行Training的"专用Models"。 However, with the rise of foundation model technology, this landscape is undergoing a fundamental change。 A general-purpose vision foundation model pre-trained on large-scale medical imaging data can be adapted to a wide range of downstream tasks with only minimal fine-tuning, greatly reducing the cost and cycle of model development。

In 2025, several top international teams successively released foundation models designed specifically for medical imaging。These models are pre-trained on hundreds of millions or even billions of medical images, learning rich feature representations of medical images。在乳腺Ultrasound(Ultrasound)Tasks上,这些基础Models展现出了惊人的性能, setting new state-of-the-art records on multiple benchmarks。More importantly, they demonstrate powerful generalization capability and few-shot learning ability, providing a new approach to solving the "data scarcity" pain point in the field of medical AI。

Changsha Langhui Information Technology Co., Ltd. is also actively positioning itself in this direction。基于40,000+例乳腺Ultrasounddata乳腺Imagingdata, LanghuiResearch院正在Training专门针对乳腺Ultrasound(Ultrasound)的Domains基础Models。 Preliminary results show that the model achieved excellent performance across multiple breast disease diagnosis tasks, Compared with traditional single-task models, performance improves significantly and generalization capability is stronger。

Technology Insights:Three Major Challenges of Medical Imaging Foundation Models

  • Data Quality Challenges:Annotation of medical imaging data requires professional knowledge, and high-quality annotated data is scarce
  • Domain Adaptation Challenges:Directly transferring general-purpose vision foundation models to the medical domain yields limited results; domain-specific pre-training is required
  • Explainability Challenges:The "black box" nature of large models poses regulatory and clinical trust challenges in medical settings

4.2 Self-Supervised Learning:Unleashing the Huge Value of Unlabeled Data

In medical imaging, annotated data is costly and time-consuming to acquire, while unlabeled data is relatively abundant。 How to effectively leverage massive amounts of unlabeled data has always been one of the core topics in medical AI research。 The maturity of self-supervised learning technology provides an effective solution to this problem。

2025 Years以来,自监督学习在乳腺Ultrasound(Ultrasound)Domains取得了一系列重要进展。 By designing ingenious pre-training tasks (such as image inpainting, contrastive learning and masked image modeling), allowing models to learn useful feature representations from massive amounts of unlabeled ultrasound images。 Experiments show that models pretrained with self-supervised learning can match or even exceed fully supervised training results on downstream diagnostic tasks using only a small amount of annotated data。

This technological breakthrough has important practical significance。It means that for some rare and uncommon diseases, Even with limited annotated data, self-supervised pre-training can be used to build AI models with strong performance。 At the same time, self-supervised learning offers a new paradigm for multi-center data collaboration — individual centers do not need to share raw data or annotations, Simply sharing the knowledge from model pre-training enables collective progress。

4.3 Multimodal Fusion:Comprehensive Diagnosis Integrating Imaging, Clinical and Genomic Data

Clinical diagnosis has never been a single-modality decision。In real clinical practice, doctors need to comprehensively consider the patient's imaging findings, Clinical symptoms, laboratory tests, family history and even genetic test results must all be considered to arrive at the most accurate diagnosis。 Multimodal fusion technology is precisely what enables AI to acquire such comprehensive analytical capability。

In 2025-2026, multimodal fusion made remarkable progress in breast disease diagnosis。 Researchers have developed a variety of effective multimodal fusion strategies, including early fusion, late fusion and hybrid fusion architectures, as well as attention-mechanism-based cross-modal feature interaction methods。 These technologies enable AI models to simultaneously process ultrasound images, clinical text, laboratory data and other types of information, outputting more comprehensive and more precise diagnostic results。

以乳腺肿瘤诊断为例,MultimodularAIModels不仅能够分析Ultrasound(Ultrasound)Image中的肿瘤形态学特征, It can also incorporate the patient's tumor marker levels, clinical manifestations, genetic test results and other information, making more accurate predictions of tumor benignity and malignancy, invasiveness and prognosis, providing clinicians with more valuable decision support。

4.4 Empowerment by Large Language Models:End-to-End Intelligence from Image to Report

The rise of large language models (Large Language Model, LLM) has opened up new possibilities for ultrasound AI。 By combining vision models with language models to build vision-language multimodal large models, enabling the direct generation of structured, standardized diagnostic reports from ultrasound images, This will greatly improve the work efficiency of radiology departments。

In 2025, several research teams have already achieved important breakthroughs in this direction。 The vision-language model they built can not only accurately identify various breast lesions, It can also generate imaging reports that comply with clinical standards and have a clear structure。 Even more exciting is that these models also possess a certain "conversational" capability, Doctors can interact with the model in natural language, asking various questions about the image, This brings a brand-new human-machine collaboration experience to clinical work。

4.5 Explainable AI: Transparent and credible AI decision-making

In the medical field, the explainability of AI models is of critical importance。A "black box" AI system, No matter how high the performance, it is difficult to gain the trust of clinicians and the approval of regulators。 In 2025-2026, explainable AI (Explainable AI, XAI) made important progress in the field of ultrasound。

Research人员开发出了多种针对乳腺Ultrasound(Ultrasound)AI的可解释性方Law, Including attention-based visualization methods, feature attribution-based explanation methods, concept activation vectors and more。 These methods allow doctors to clearly see which regions and which features of the image the AI model based its diagnostic decision on, greatly enhancing the transparency and trustworthiness of AI systems。

Changsha Langhui Information Technology Co., Ltd. has also conducted in-depth exploration in explainable AI。 Langhui's breast AI system not only provides diagnostic conclusions, It also presents the basis of the model's decisions to doctors through heatmaps, feature annotations and other means, allowing doctors to "know not only what the AI concludes, but also why" when using AI assistance。

Key References

  • The Lancet Oncology(2025):Artificial intelligence for breast ultrasound screening: a prospective multicenter study
  • Journal of Clinical Oncology(2024):Deep Learning-Based Ultrasound for Breast Cancer Detection in Dense Breasts
  • Radiology(2025):AI-Assisted Breast Ultrasound for Reducing False-Positive Findings in Screening Programs

05 Core Value of Langhui Datasets

In the development of artificial intelligence, data is the foundation and, even more so, the core competitiveness。在乳腺Ultrasound(Ultrasound)AIDomains, High-quality, large-scale, multi-center datasets are the fundamental guarantee of model performance。 Changsha Langhui Information Technology Co., Ltd.经过多years of deep expertise,构建了国内领先的乳腺Ultrasound(Ultrasound)ImagingDataset, providing a solid data foundation for industry development。

5.1. Data Scale:Massive Data Underpins the Ceiling of Model Performance

40,000+
Data Volume
38+
Partner Hospitals
Parameters of pathogen, triblind, 99.0% accuracy
Annotation Quality
Escaping +BI-RADS + Good and Malignant Assessment + Molecular Subtypes are more predicted
Annotation Dimensions

Langhui乳腺Ultrasound(Ultrasound)DatasetIncludes40,000+例乳腺Ultrasounddata, covering a rich set of cases including healthy individuals, patients with various diseases and different severity levels。 Such large-scale data accumulation provides ample "fuel" for the training of deep learning models, ensuring that the model can learn rich and diverse breast imaging features, maintaining stable performance across a wide variety of complex clinical scenarios。

The importance of data scale is self-evident。Studies show that, within a certain range, AI model performance improves continuously as the volume of training data increases。 The scale advantage of Langhui datasets translates directly into a performance advantage for models。 Whether in diagnostic accuracy for common diseases or in the ability to recognize rare diseases, Models trained on Langhui datasets have all demonstrated clear advantages。

5.2. Annotation Quality:High Standards Forge High Precision

If data scale determines the ceiling of model performance, then annotation quality determines whether the model can actually reach that ceiling。 In medical imaging, data annotation is a highly specialized and extremely demanding task。 Langhui Technology has established a rigorous and comprehensive data annotation quality control system to ensure the accuracy and reliability of every piece of annotated data。

Langhui Data Annotation Quality Control System

1
Initial Annotation
Initial annotation is performed by rigorously trained professional annotators
→
2
Cross-Review
Two annotators annotate independently, and discrepancies are discussed and corrected
→
3
Expert Review
Senior clinical / imaging experts perform the final review of annotation results
→
4
Gold Standard Comparison
Cross-validated against gold standards such as pathology results / clinical follow-up

Langhui乳腺Dataset采用Escaping +BI-RADS + Good and Malignant Assessment + Molecular Subtypes are more predicted维AnnotationSystem, ensuring the comprehensiveness and systematicity of data annotation。 The annotation team consists of professionally trained medical imaging annotators, 并由Parameters of pathogen, triblind, 99.0% accuracy。 Such a rigorous quality control system ensures the high quality of the dataset and lays a solid foundation for high model performance。

5.3 Multi-Center Data:Guaranteed Generalization Capability in the Real World

AI models trained on single-center data often face the risk of "overfitting" — performing excellently on the training data, but performance drops significantly on data from other hospitals and other equipment。This is also why many medical AI products "look great" in demonstrations, but is one of the important reasons for poor deployment results。

Langhui乳腺DatasetSource于38家三甲医院乳腺中心多中心data, covering real-world data from different regions, different hospital tiers and different equipment vendors。 This multi-center data sourcing ensures the diversity and representativeness of the dataset, It also gives AI models trained on this dataset stronger generalization capability and robustness。

The value of multi-center data has been fully validated。In multiple clinical validation studies conducted by Langhui, Models trained on multi-center data maintained consistently high performance on external validation sets from different hospitals, demonstrating strong cross-center generalization capability。This is crucial for the real clinical deployment of AI products。

5.4 Data Compliance:Strictly Safeguarding Data Security and Privacy

Medical data involves patient privacy; data security and compliance are red lines that must not be crossed。 Changsha Langhui Information Technology Co., Ltd. always puts data security and privacy protection first, and has established a comprehensive data compliance management system。

Ethics Review

All data collection has been reviewed by the ethics committee, with informed consent obtained from patients

Data De-identification

Strict de-identification processing ensures that patient privacy is not disclosed

Secure Storage

A data center certified at Level 3 of the Multi-Level Protection Scheme, with multi-layer encryption protecting data security

Compliant Use

Strict data usage approval procedures ensure compliant and lawful use of data

"Data is the cornerstone of medical AI。Langhui's pursuit of data quality cannot be overemphasized。 We do not pursue the largest data volume, but we do pursue the highest data quality。 Every annotation and every piece of data must withstand clinical scrutiny。"

—— Director of Data Science, Changsha Langhui Information Technology Co., Ltd.

06 Clinical Application Scenarios and Value

The value of technology must ultimately be reflected in clinical application。基于LanghuiHigh-quality data sets开发的乳腺Ultrasound(Ultrasound)AI系统, demonstrating significant application value across multiple clinical scenarios。The following are five core clinical application scenarios。

01

Good and bad diagnosis of the mammogram.

AI technology can provide accurate quantitative assessment and intelligent decision support in this scenario, helping clinical practitioners to improve diagnostic accuracy and efficiency, and providing patients with better clinical experience and pre- and post-effects.

02

BI-RADS Level Auto-Assessment and Standardization Report

AI technology can provide accurate quantitative assessment and intelligent decision support in this scenario, helping clinical practitioners to improve diagnostic accuracy and efficiency, and providing patients with better clinical experience and pre- and post-effects.

03

Early prediction of the effects of new assisted chemotherapy for breast cancer

AI technology can provide accurate quantitative assessment and intelligent decision support in this scenario, helping clinical practitioners to improve diagnostic accuracy and efficiency, and providing patients with better clinical experience and pre- and post-effects.

04

Additional screening of the population for the membrane breast

AI technology can provide accurate quantitative assessment and intelligent decision support in this scenario, helping clinical practitioners to improve diagnostic accuracy and efficiency, and providing patients with better clinical experience and pre- and post-effects.

05

Quality control and equalization of breast ultrasound screening

AI technology can provide accurate quantitative assessment and intelligent decision support in this scenario, helping clinical practitioners to improve diagnostic accuracy and efficiency, and providing patients with better clinical experience and pre- and post-effects.

6.1 Screening Scenario:Early Screening and Early Diagnosis for Large Populations

Early detection and intervention of breast diseases are of great significance for improving patient prognosis and reducing medical costs。 However, the traditional manual screening model faces many challenges, including low efficiency, high cost and uneven quality。 The introduction of AI technology provides strong technical support for large-scale breast disease screening。

AI screening systems trained on Langhui datasets can quickly and accurately identify abnormal cases from a large number of ultrasound examinations, concentrating limited medical resources on the patients who need attention most。This not only improves screening efficiency and reduces screening costs, More importantly, the homogenized diagnostic capability of AI ensures consistency of screening quality across different regions and institutions, enabling more patients to benefit from high-quality screening services。

6.2 Assisted Diagnosis Scenario:Improving Diagnostic Accuracy and Efficiency

In daily clinical work, the ultrasound AI system acts as the doctor's "intelligent assistant", providing support to doctors from multiple dimensions。 The first is automatic detection and localization of lesions, helping doctors quickly find suspicious abnormalities and reduce missed diagnoses; The second is quantitative analysis of lesions, providing precise quantitative indicators such as size, shape and texture; The third is benign-malignant differentiation and risk stratification, helping doctors make more accurate diagnostic decisions; The last is automatic report generation, substantially reducing doctors' documentation workload。

Clinical验证结果显示,引入AI辅助后,医生对乳腺疾病的诊断Accuracy和Diagnostic Consistency都有显著提升, while report turnaround time is significantly shortened。This means patients can obtain accurate diagnostic results more quickly, Doctors are also freed from heavy workloads and can devote more energy to clinical decision-making and patient communication。

6.3 Prognosis Prediction Scenario:The Leap from Diagnosis to Prediction

In the era of precision medicine, clinical management of breast diseases is no longer satisfied with a simple "is there a disease or not" diagnosis, but focuses more on prognostic questions such as "how will it progress" and "which treatment will work better"。 AI prognosis prediction based on ultrasound images is becoming a rapidly developing direction。

Langhui乳腺AI系统不仅能够诊断疾病,还能够通过分析Ultrasound(Ultrasound)Image中的深层次特征, predicting disease progression risk, treatment response, survival prognosis and more。 This provides an important reference for clinicians to formulate individualized treatment plans and perform precise patient management, truly realizing a value leap from "diagnosis" to "prediction"。

6.4 Treatment Monitoring Scenario:Dynamically Assessing Treatment Efficacy

对于接受治疗的乳腺疾病患者,定期的Ultrasound(Ultrasound)随访是评估疗效、调整治疗方案的重要依据。 However, traditional manual assessment suffers from strong subjectivity and insufficient sensitivity, making it difficult to accurately capture subtle changes in disease。

The introduction of AI technology has changed this situation。Based on precise quantitative analysis capability, AI systems can perform objective and precise comparative assessment of ultrasound images before and after treatment, sensitively capturing the trend of disease changes。This not only helps clinicians assess treatment efficacy and adjust treatment plans in a timely manner, it also provides a more precise efficacy assessment tool for new drug development and clinical trials。

6.5 Primary Care Empowerment Scenario:Supporting the Implementation of Tiered Diagnosis and Treatment

The uneven distribution of medical resources in China has long been a problem, with high-quality ultrasound diagnostic resources heavily concentrated in large cities and large hospitals。 Ensuring that primary-care patients can also access high-quality imaging diagnostic services is a key step in advancing tiered diagnosis and treatment and realizing the Healthy China strategy。

Changsha Langhui Information Technology Co., Ltd. actively responds to the national tiered diagnosis and treatment policy, empowering primary-care medical institutions with AI technology。 Langhui的乳腺Ultrasound(Ultrasound)AI系统已经在全国多家基层Medical Institutions落地应用, helping primary-care physicians improve their ability to diagnose breast diseases, enabling primary-care patients to receive imaging diagnostic services at Grade-A Tertiary Hospital standards right on their doorstep。 This not only makes it more convenient for patients to seek care, but also promotes the implementation of the tiered diagnosis and treatment system。

The Comprehensive Value of AI in Clinical Application

For Patients

Earlier detection, more accurate diagnosis, better prognosis, less waiting

For Doctors

Improve efficiency, reduce missed diagnoses, assist decision-making, lighten the burden

For Hospitals

Improve quality, optimize workflows, reduce costs and enhance competitiveness

For Society

Homogenized care, tiered diagnosis and treatment, early screening and early treatment, reduced burden

07 Industry Outlook and Future Trends

站在2025 Years的时间节点上展望未来,乳腺Ultrasound(Ultrasound)AIIndustries正处于一个快速发展的关键时期。 Accelerating technology iteration, maturing regulatory policies, deepening clinical application and a maturing industrial ecosystem are multiple factors jointly driving the industry forward。 The following are our judgments on industry development trends over the coming years。

7.1 Accelerated Implementation of Regulatory Policies and Standardized Industry Development

With the rapid development of medical AI technology, related regulatory policies are also being refined at an accelerated pace。 The National Medical Products Administration has issued a number of guiding principles and review standards for artificial intelligence medical devices, pointing the way forward for the standardized development of the industry。未来几年,预计将有更多的乳腺Ultrasound(Ultrasound)AIProducts获得NMPA三类证, Officially Entering Clinical Application。

Improved regulation is both a challenge and an opportunity for the industry。On the one hand, higher entry barriers mean that enterprises need to invest more resources in product R&D, investing more resources in clinical trials, quality management and other areas;On the other hand, a well-regulated market environment will also eliminate a number of non-compliant enterprises, allowing enterprises with genuine technical strength and product quality to stand out。 Changsha Langhui Information Technology Co., Ltd. has always adhered to a compliance-first development philosophy and actively cooperates with regulatory requirements, 推动乳腺Ultrasound(Ultrasound)AIProducts的Compliance化和Clinical化进程。

Timeline of Medical AI Regulation Development

2024
The review standard system for AI medical devices has been basically established, and multiple products have entered the green channel
2025
Several ultrasound AI products have obtained Class III medical device certificates and entered the stage of large-scale clinical application
2026
Exploration of including AI-assisted diagnosis in medical insurance reimbursement is underway, and commercial application models are gradually maturing
2027+
AI becomes a standard feature of ultrasound diagnosis, deeply integrated into clinical workflows

7.2 Deepening Technology Integration: From Single-Point Breakthrough to Full-Workflow Empowerment

当前的乳腺Ultrasound(Ultrasound)AI Applications,大多还集中在疾病诊断这一单点上。 In the future, AI technology will permeate the entire imaging examination workflow, from pre-examination patient preparation and scan protocol design, to image acquisition optimization and quality control during the examination, and then to image analysis and report generation afterwards, ultimately extending to clinical decision support and patient management, enabling intelligent empowerment across the entire workflow。

At the same time, the integration of multiple AI technologies will continue to deepen。The combination of foundation models and task-specific models, The integration of vision models with language models, and the connection of imaging AI with clinical decision support systems, building a more complete and more intelligent medical AI ecosystem。 Changsha Langhui Information Technology Co., Ltd.正在积极布局这一方向,致力于打造Coverage乳腺Ultrasound(Ultrasound)Full Workflow的AISolutions。

7.3 Accelerated Industrialization and Increasingly Mature Business Models

随着技术成熟和监管完善,乳腺Ultrasound(Ultrasound)AI的产业化进程正在加速。 A growing number of medical institutions have begun to procure and use AI products, and AI has shifted from a "research tool" to a "clinical tool"。 At the same time, business models are also constantly innovating and improving, moving from single software sales, to a variety of coexisting models including per-case fees, annual service fees, joint research and screening services。

It is worth noting that the exploration of AI medical insurance reimbursement is also steadily advancing。Some regions have begun to include AI-assisted diagnostic items within the scope of medical insurance reimbursement, This will inject strong momentum into industry development。It is expected that over the next 3-5 years, as the payment side gradually opens up, 乳腺Ultrasound(Ultrasound)AI市场将迎来爆发式增长。

7.4 Ecosystem-Based Data Collaboration: Win-Win Development Becomes Consensus

Data is the core asset of medical AI, but the data held by any single company or institution is limited。 In the future, cross-institution and cross-region data collaboration will become an inevitable trend in industry development。 The maturity of technologies such as federated learning and privacy-preserving computing has made data collaboration technically possible while protecting data security and privacy。

Changsha Langhui Information Technology Co., Ltd. actively advocates an open and collaborative industry ecosystem, and has established in-depth partnerships with multiple top hospitals and research institutions。 Langhui相信,只有通过开放Partnership、Win-Win发展,才能推动整个乳腺Ultrasound(Ultrasound)AIIndustries的持续进步。 Going forward, Langhui will continue to uphold the philosophy of openness and cooperation, working with industry partners to jointly advance the development of medical AI。

"The future of medical AI is not a solo performance by any single company, but a symphony of the entire industry。 Langhui愿意以开放的心态,与Industries伙伴携手共进,共同推动乳腺Ultrasound(Ultrasound)AI技术的发展和应用, allowing more patients to benefit from the advantages brought by AI technology。"

—— Founder and CEO, Changsha Langhui Information Technology Co., Ltd.

08 Conclusion

乳腺Ultrasound(Ultrasound)AI正处于前所未有的发展机遇期。From technological breakthrough to clinical application, From maturing regulation to a maturing industry, the entire sector is advancing rapidly。 We have reason to believe that in the near future, AI will become an indispensable tool for ultrasound diagnosis, making important contributions to improving the diagnosis and treatment of breast diseases and the quality of medical services。

作为Industries的先行者和引领者,Changsha Langhui Information Technology Co., Ltd.将继续深耕乳腺Ultrasound(Ultrasound)AIDomains, Built on high-quality data, driven by frontier technology and guided by clinical needs, continuously launching more and better AI products and services, empowering doctors, benefiting patients and contributing to the implementation of the Healthy China strategy。

The future has come, so let's all look forward to a better tomorrow for Ultrasoon.

About Changsha Langhui Information Technology Co., Ltd.

Changsha Langhui Information Technology Co., Ltd. is a high-tech enterprise focused on medical artificial intelligence, committed to empowering healthcare with AI technology。 The company possesses domestically leading medical imaging datasets and a first-class AI R&D team, The products cover multiple medical imaging modalities and disease areas, and have been deployed in hundreds of medical institutions nationwide。 Langhui Technology has always adhered to the philosophy of "patient-centered, clinically oriented", continuously advancing the innovation and deployment of medical AI technology, contributing Langhui's strength to Healthy China。